Immunoblotting of insoluble fractions extracted from transfected cells showed that insoluble tau from cells treated with PSP-, CBD-, and AD-tau seeds was pS262-positive, while that from cells treated with PiD-tau seeds was pS262-negative (Fig. 7C and Supplementary Fig. 7, C). The gene discussed is MAPT; the disease is Alzheimer disease.